Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Raising a low MCHC starts with correcting its cause, most often iron deficiency, which is typically addressed through iron-rich foods like red meat, liver, beans, lentils, spinach and fortified cereals, plus vitamin C to boost absorption and iron supplements when a clinician recommends them. Because low MCHC can also stem from ongoing blood loss such as heavy periods or gastrointestinal bleeding, celiac disease, thalassemia, vitamin B6 deficiency, hypothyroidism, or chronic inflammatory conditions, food and supplements alone may not resolve it. Timelines, dosing cautions, and warning signs that call for prompt testing vary from person to person, so there are several important factors to consider before starting any regimen, as explained below.
If you are unsure whether your low MCHC points to simple iron deficiency or something that needs a closer look, a free, instant, online symptom check can help you connect your fatigue, pallor, or other symptoms to likely causes in just a few minutes. It is a private, no-cost way to organize what you are experiencing, learn which tests and specialists are usually involved, and walk into your next appointment ready with the right questions.
Last reviewed for medical accuracy: 09/15/2025
If you’ve been told you have “mchc low,” you might be wondering what it means and how to address it. Mean Corpuscular Hemoglobin Concentration (MCHC) measures the average concentration of hemoglobin in your red blood cells. When MCHC is low, your cells carry less hemoglobin than they should, which can affect oxygen delivery throughout your body. Below, you’ll find clear, evidence-based steps to help raise your MCHC level safely and effectively.
MCHC is part of a routine complete blood count (CBC). A normal MCHC typically ranges from 32 to 36 g/dL. Values below this suggest hypochromia (less color) in your red blood cells. Common signs of mchc low include:
Keep in mind that mild mchc low often improves with targeted diet and lifestyle changes. However, it’s always wise to track your numbers and symptoms over time.
Identifying the root cause of mchc low helps guide treatment. Some common contributors include:
What you eat has a direct impact on hemoglobin production and the concentration of hemoglobin in each red blood cell. Consider these nutrition tips:
Vitamin C helps convert iron into a form your body can absorb more easily. Pair iron sources with:
Even if iron is the main issue, B12 and folate support healthy red blood cell formation:
Hemoglobin is a protein, so a balanced intake supports overall red cell health:
If dietary changes alone don’t bring your mchc level back into range—or if tests show severe iron deficiency—supplements may help. Always discuss supplements with your doctor before starting.
Monitor for side effects such as constipation or stomach upset, and adjust dosage under medical supervision.
Beyond food and supplements, small lifestyle tweaks can make a difference:
If mchc low persists despite diet and supplements, further medical evaluation may be necessary:
Most cases of mchc low respond well to the steps above. However, if you experience any of the following, don’t hesitate to reach out for professional evaluation:
You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify your next steps.
Ultimately, only a healthcare provider can diagnose serious issues. If you have life-threatening or worrisome symptoms, please speak to a doctor right away.
By focusing on nutrient-dense foods, smart supplementation and close coordination with your doctor, you can raise your MCHC level and support overall blood health. Remember, if anything feels off or potentially serious, speak to a doctor without delay.
(References)
* Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009 Aug 15;80(4):339-44. PMID: 19678601.
* Loprinzi PD, Loenneke JP, Abe T. The association between muscle strengthening activities and red blood cell distribution width among a national sample of U.S. adults. Prev Med. 2015 Apr;73:130-2. doi: 10.1016/j.ypmed.2015.01.011. Epub 2015 Jan 17. PMID: 25602910.
* Latagliata R, Montagna C, Porrini R, Di Veroli A, Leonetti SC, Niscola P, Ciccone F, Spadea A, Breccia M, Maurillo L, Rago A, Spirito F, Cedrone M, De Muro M, Montanaro M, Andriani A, Bagnato A, Montefusco E, Alimena G. Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. Eur J Haematol. 2016 Jun;96(6):643-9. doi: 10.1111/ejh.12674. Epub 2015 Sep 18. PMID: 26277477.
* Basora Macaya M, Bisbe Vives E. [The first pillar of patient blood management. Types of anemia and diagnostic parameters]. Rev Esp Anestesiol Reanim. 2015 Jun;62 Suppl 1:19-26. doi: 10.1016/S0034-9356(15)30003-7. PMID: 26320340.
* De Falco L, Tortora R, Imperatore N, Bruno M, Capasso M, Girelli D, Castagna A, Caporaso N, Iolascon A, Rispo A. The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease. Am J Hematol. 2018 Mar;93(3):383-393. doi: 10.1002/ajh.24991. Epub 2017 Dec 18. PMID: 29194702.
* Pasini E, Corsetti G, Romano C, Aquilani R, Scarabelli T, Chen-Scarabelli C, Dioguardi FS. Management of Anaemia of Chronic Disease: Beyond Iron-Only Supplementation. Nutrients. 2021 Jan 15;13(1). doi: 10.3390/nu13010237. Epub 2021 Jan 15. PMID: 33467658; PMCID: PMC7830481.
* Yamaguchi S, Hamano T, Oka T, Doi Y, Kajimoto S, Shimada K, Matsumoto A, Sakaguchi Y, Matsui I, Suzuki A, Isaka Y. Mean corpuscular hemoglobin concentration: an anemia parameter predicting cardiovascular disease in incident dialysis patients. J Nephrol. 2022 Mar;35(2):535-544. doi: 10.1007/s40620-021-01107-w. Epub 2021 Jul 2. PMID: 34213761.
* Valko L, Baglyas S, Podmaniczky E, Prohaszka Z, Gal J, Lorx A. Exploring red cell distribution width as a biomarker for treatment efficacy in home mechanical ventilation. BMC Pulm Med. 2022 Mar 30;22(1):115. doi: 10.1186/s12890-022-01916-0. Epub 2022 Mar 30. PMID: 35354396; PMCID: PMC8969261.
* Yang W, Li Y, Ma L, Tan Y, Zhou F, Zhou Z, Wang J. The impact of hyperthyroidism on the hematopoietic system. Clin Exp Med. 2025 Dec 20;26(1):85. doi: 10.1007/s10238-025-01999-z. Epub 2025 Dec 20. PMID: 41420729; PMCID: PMC12769996.
* Singh SK, Arora R, Pramanik SK, Kumar A, Singh A, Khanna S, Malhotra N, Juneja P, Upadhyay N, Yanamandra U. Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial. Am J Hematol. 2026 Sep;101(9):2343-2352. doi: 10.1002/ajh.70433. Epub 2026 Jul 2. PMID: 42393020; PMCID: PMC13428384.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.